Bionaut Labs is pioneering the use of precision micro-technology to revolutionize healthcare by enabling localized treatment and diagnostic detection in deep regions of the human body. Their innovative approach utilizes microscale wireless robots, known as Bionauts, which are propelled through complex 3D trajectories using external magnetic fields. This technology allows for accurate navigation through various tissue types, including dense tumors and fibrous tissues, while minimizing the risks associated with traditional invasive procedures. The Bionauts are designed to deliver a range of therapeutic payloads, including small molecules, biologics, and gene therapies, directly to targeted disease areas, thereby enhancing treatment efficacy and safety.

The Bionaut platform is characterized by its modular design, which allows for customization based on specific anatomical and therapeutic needs. Each Bionaut can be tailored in size, shape, and function to address different medical conditions, such as hydrocephalus, Dandy Walker Malformation, and brain tumors. By automating and standardizing the delivery process, Bionaut Labs aims to reduce treatment variability and improve patient outcomes. This technology not only facilitates localized treatment but also enables real-time monitoring and diagnostics, marking a significant advancement in the management of severe brain disorders and other complex health issues.

United States

By creating a new medical modality of remote-controlled micro-robots called Bionauts™ we can transform the way the biopharmaceutical industry develops treatments, allowing us to engineer the therapeutic index for efficacy and maintain safety.

Bionaut Labs

Company Details